Most lately, it's been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to your big range of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://herbertq738lbq3.prublogger.com/profile